Previous MondayTuesdayWednesdayThursdayFridayNext

Posted February 23, 2012

Assistive Technologies

U.S. Millipore Execs Visiting Toronto to Formalize Large-scale Stem Cell Cultivation Partnership

Toronto – Millipore executives from Boston, MA, will be in Toronto next week to sign papers and tour the product development facility at the Centre for Commercialization of Regenerative Medicine (CCRM) at the University of Toronto. CCRM, launched in June 2011, has signed its first industry project with EMD Millipore, the Life Sciences division of Merck KGaA, to translate 2D tissue culture vessels into 3D tissue bioreactors .

“We are delighted that Robert Shaw and Knut Niss are coming to Toronto to see where CCRM will be producing stem cells on a scale that is large enough to be cost-effective for clinical use,” says Michael May, CEO of the Centre for Commercialization of Regenerative Medicine. “We anticipate that this project will be the first of many industry collaborations and it’s a pleasure to have our Millipore partners on site to kick this one off.”

Submit press release to - Editor Jon Rohr - Content published on this site represents the opinion of the individual/organization and/or source provider of the Content. is non-partisan, online journal. Privacy Policy. Copyright of Exchange produced editorial is the copyright of Exchange Business Communications Inc. 2012/*.*. Additional editorials, comments and releases are copyright of respective source(s) and/or institutions or organizations.


Contact an Exchange Representative

Current Exchange Magazine:
March/April 2012

Read It On The Web

Submit Press Release
Visitor Centre
Advertising Inquires
Tel: 519.886.0298

Subscribe to Exchange Magazine -

Contact Information:

Exchange Business Communication Inc.
Waterloo, Ontario
, Canada

Contact Editors

Print Editor - Paul Knowles
Daily Editor - Jon Rohr

Account Manager Sales
John Hobin

Account Manager Sales
Dan Manseau

Administration & Sales Support
Wanda Jackson